Published in Chest on January 01, 2001
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83
Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ (2003) 3.73
Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest (2010) 1.18
Deep vein thrombosis: a clinical review. J Blood Med (2011) 1.15
A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med (2010) 1.04
Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon. Br J Clin Pharmacol (2014) 0.97
Inferior vena cava filters for recurrent thrombosis: current evidence. Tex Heart Inst J (2007) 0.96
Treatment of deep vein thrombosis: what factors determine appropriate treatment? Can Fam Physician (2005) 0.92
A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment. J Thromb Thrombolysis (2016) 0.91
Bilateral upper-extremity deep vein thrombosis following central cord syndrome. J Spinal Cord Med (2013) 0.88
Venous thromboembolism: A problem in the Indian/Asian population? Indian J Urol (2009) 0.85
Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients. J Pediatr Pharmacol Ther (2010) 0.83
Instructive ECG series in massive bilateral pulmonary embolism. Heart (2005) 0.83
Increase in venous complications associated with etomidate use during a propofol shortage: an example of clinically important adverse effects related to drug substitution. Ochsner J (2011) 0.83
Respiratory review of 2013: pulmonary thromboembolism. Tuberc Respir Dis (Seoul) (2013) 0.82
Mechanical interventions and thrombolytic therapy in venous thrombosis and pulmonary embolism. Ochsner J (2002) 0.81
Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis. J Gen Intern Med (2016) 0.81
Reversal of the anticoagulant and anti-hemostatic effect of low molecular weight heparin by direct prothrombin activation. Braz J Med Biol Res (2012) 0.81
Ambulation after deep vein thrombosis: a systematic review. Physiother Can (2009) 0.79
Thrombolytic and anticoagulant therapy for acute submassive pulmonary embolism. Exp Ther Med (2013) 0.79
Outcomes considered most important by emergency physicians when determining disposition of patients with pulmonary embolism. Int J Emerg Med (2010) 0.78
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants. Vasc Health Risk Manag (2009) 0.78
A New Frontier: Integrating Behavioral and Digital Technology to Promote Health Behavior. Behav Anal (2014) 0.77
Venous Thrombosis of the Upper Extremities. Curr Treat Options Cardiovasc Med (2001) 0.77
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. J Thromb Thrombolysis (2016) 0.77
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies. Clin Interv Aging (2013) 0.77
The new heparins. Ochsner J (2002) 0.76
Routine home treatment of deep vein thrombosis. BMJ (2001) 0.76
Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines. Vasc Specialist Int (2016) 0.75
Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) study. Medicine (Baltimore) (2016) 0.75
Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery. Knee Surg Sports Traumatol Arthrosc (2016) 0.75
Evaluation of GenoFlow Thrombophilia Array Test Kit in its detection of mutations in Factor V Leiden (G1691A), prothrombin G20210A, MTHFR C677T and A1298C in blood samples from 113 Turkish female patients. Genet Test Mol Biomarkers (2014) 0.75
Long-term, low-intensity warfarin after idiopathic venous thromboembolism. CMAJ (2003) 0.75
Anticoagulation for the acute management of ischemic stroke. Yale J Biol Med (2014) 0.75
Inflammatory Bowel Disease and Cerebral Venous Sinus Thrombosis. Gastroenterol Hepatol (N Y) (2006) 0.75
Significant omission in antithrombotic supplement. Chest (2002) 0.75
The hypercoagulable states in anaesthesia and critical care. Indian J Anaesth (2014) 0.75
The clinical course of pulmonary embolism. N Engl J Med (1992) 3.70
Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med (1997) 3.48
Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management. Ann Intern Med (1994) 3.44
Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys (1997) 3.17
Venous thromboembolism during pregnancy. N Engl J Med (1996) 3.11
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med (1986) 3.00
Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med (1996) 2.88
Pulmonary dysfunction in rheumatoid disease. Chest (1973) 2.84
Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg Br (2007) 2.53
Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation (2000) 2.41
Pulmonary artery flow directed catheter: the evidence. Lancet (1996) 2.02
Infections in patients with cystic fibrosis following lung transplantation. Chest (1997) 1.98
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. J Thromb Haemost (2003) 1.95
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest (1985) 1.92
Respiratory rate as an indicator of acute respiratory dysfunction. JAMA (1980) 1.82
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med (1999) 1.80
Recommendations on biosimilar low-molecular-weight heparins. J Thromb Haemost (2009) 1.68
Antithrombotic therapy for venous thromboembolic disease. Chest (1998) 1.67
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med (1986) 1.67
Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ (1991) 1.65
Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol (2001) 1.59
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. J Thromb Haemost (2003) 1.57
Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med (1983) 1.51
The diagnosis of acute pulmonary embolism in patients with chronic obstructive pulmonary disease. Chest (1992) 1.51
Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes. Heart (2007) 1.47
Tuberculous enteritis and peritonitis. Report of 36 general hospital cases. Arch Intern Med (1980) 1.46
Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Arch Intern Med (1994) 1.44
Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis. Thromb Haemost (1993) 1.44
PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol (1992) 1.43
A European view on the North American fifth consensus on antithrombotic therapy. Chest (2000) 1.43
Pain management in internal medicine and effects of a standardised educational intervention: the FADOI-DOMINO study. Int J Clin Pract (2014) 1.40
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests. Am J Med (2000) 1.40
Cerebral infarction and familial protein S deficiency. Stroke (1990) 1.39
Rapid aequorin loading into platelets in the presence of DMSO--characteristics of the responses (changes in light transmission and in calcium) to various agonists. Thromb Haemost (1991) 1.38
Spiral computed tomography is the first-line chest imaging test for acute pulmonary embolism: no. J Thromb Haemost (2005) 1.38
The dependence of oxygen uptake on oxygen delivery in the adult respiratory distress syndrome. Am Rev Respir Dis (1980) 1.36
Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy. Ann Intern Med (1970) 1.33
Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin. Lancet (1992) 1.29
Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost (1995) 1.28
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet (1987) 1.25
Diagnosis of upper airway obstruction by pulmonary function testing. Chest (1975) 1.25
Clinical characteristics of patients with acute pulmonary embolism. Am J Cardiol (1991) 1.24
[Coagulation disorders after reinjection of concentrated ascitic fluid. Preliminary study]. Med Chir Dig (1973) 1.22
Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery (1994) 1.22
The incidence of urine cultures positive for Mycobacterium tuberculosis in a general tuberculosis patient population. Am Rev Respir Dis (1975) 1.22
Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation (1992) 1.20
Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis (1979) 1.20
Small abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: predisposing factors and effect on thromboembolism. J Heart Valve Dis (1993) 1.19
Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res (2010) 1.18
The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. Int J Radiat Oncol Biol Phys (1993) 1.17
The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat. Thromb Haemost (1996) 1.17
Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations. Arterioscler Thromb Vasc Biol (1997) 1.17
Isolated monoparesis following stroke. J Neurol Neurosurg Psychiatry (2005) 1.17
An index of risk for obstructive airways disease. Am Rev Respir Dis (1982) 1.17
Antithrombotic therapy for venous thromboembolic disease. Chest (1995) 1.17
Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). Blood (1987) 1.16
Successful progressive anticoagulation in a severe protein C deficiency and previous skin necrosis at the initiation of oral anticoagulant treatment. Thromb Haemost (1984) 1.16
The effect of tumor size and location on diagnosis by fiberoptic bronchoscopy. Chest (1977) 1.15
Intravenous thrombolysis in acute myocardial infarction. Chest (2001) 1.13
Effectiveness of the Quick Medical Reference as a diagnostic tool. CMAJ (1999) 1.13
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost (2010) 1.12
Antithrombotic therapy for venous thromboembolic disease. Chest (1989) 1.12
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial. Ann Intern Med (1985) 1.11
Persistent respiratory irregularity in patients with panic disorder. Biol Psychiatry (2001) 1.11
Pneumoperitoneum. A complication of mechanical ventilation. JAMA (1976) 1.11
[Value of the platelet count using electronic counter]. Pathol Biol (Paris) (1970) 1.11
Strategy for diagnosis of patients with suspected acute pulmonary embolism. Chest (1993) 1.10
Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral. Gastroenterology (1975) 1.08
Cervical artery dissection: emerging risk factors. Open Neurol J (2010) 1.08
Relationship between biological activity and concentration of a low-molecular-weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration. Haemostasis (1986) 1.06
Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture. Oncogene (2008) 1.06
Cryptogenic stroke: time to determine aetiology. J Thromb Haemost (2008) 1.06
Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost (2011) 1.05
Respiratory stimulation with intravenous doxapram in respiratory failure. A double-blind co-operative study. N Engl J Med (1973) 1.04
Congenital protein C deficiency and thrombotic disease in nine French families. Br Med J (Clin Res Ed) (1984) 1.04
Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med (2000) 1.03
Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration. Thromb Res (1985) 1.03
Diagnosis and management of pulmonary thromboembolism. Q J Med (1990) 1.02
Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis. J Thromb Haemost (2013) 1.02
Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension. Eur Respir J (2000) 1.02
Prevention and treatment of venous thromboembolism--International Consensus Statement. Int Angiol (2013) 1.01
Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine (Baltimore) (1996) 1.00
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost (2008) 1.00
Antithrombotic therapy for venous thromboembolic disease. Chest (1992) 1.00
Pigment versus cholesterol cholelithiasis: identification and quantification by infrared spectroscopy. Gastroenterology (1977) 0.99
Herpes simplex virus pneumonia. Occurrence in an allotransplanted lung. JAMA (1969) 0.99
Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies. Blood (1984) 0.99
Prophylaxis of venous thromboembolic disease following hip and knee surgery. J Bone Joint Surg Am (1986) 0.96